Category: Joint ventures/collaborations
-
Collaboration Collecting Data to ID Precise Cancer Meds
7 April 2015. A partnership between Caris Life Sciences and COTA, short for Cancer Outcomes Tracking and Analysis, is combining data on the chemical makeup of cancer patients with clinical outcomes information to create better profiles of cancer tumors and identify more personalized therapies. Financial details between Caris Life Sciences in Irving, Texas and COTA,…
-
Bristol-Myers Squibb Licensing Gene Therapies in $2.3B Deal
6 April 2015. Drug maker Bristol-Myers Squibb is licensing gene therapies from biotechnology company uniQure N.V. in a deal with a total potential value of $2.3 billion, including an equity stake in uniQure. The agreement gives Bristol-Myers Squibb exclusive access to as many as 10 disease programs being developed by uniQure, including a treatment for…
-
Mobile App in Development to Manage COPD
31 March 2015. A system combining an iPhone app and big data analytics is under development to help people with COPD manage their symptoms and health care providers monitor their condition. The COPD Navigator system is designed by LifeMap Solutions in San Jose, California and National Jewish Health Respiratory Institute, a joint service of National…
-
Novartis, Aduro Biotech Partner on Cancer Immunotherapy
30 March 2015. The pharmaceutical company Novartis is licensing cancer immunotherapy technology from Aduro Biotech in Berkeley, California. The collaboration could earn Aduro as much as $750 million, including an equity stake, for access to its work on cyclic dinucleotides, still in preclinical study, but considered promising as a cancer treatment. Cyclic dinucleotides are naturally…
-
Intermediate Trial Shows Ebola Vaccines Safe
27 March 2015. An intermediate-stage clinical trial in Liberia testing two new vaccines to prevent Ebola infections, shows the vaccines appear to be safe, allowing for larger-scale assessments. Initial results of the trial were reported yesterday by National Institute of Allergy and Infectious Diseases (NIAID), part of National Institutes of Health. The 2014-15 Ebola virus…
-
Biotechs Partner on Cancer Stem Cell-Gene Therapies
23 March 2015. Two biotechnology companies are combining their expertise in neural stem cells and gene delivery to develop new cancer therapies that the parties say would be more effective with fewer side effects than chemotherapy drugs used today. While GenVec Inc. in Gaithersburg, Maryland will participate economically in the collaboration with TheraBiologics Inc. in…
-
New Adaptive Aircraft Control System Flight Tested
20 March 2015. U.S. Air Force pilots tested a new flight control system designed by engineers at University of Illinois that automatically adapts aircraft to changing conditions faster than most human pilots can respond. The L1 adaptive control system is a product of the university’s Advanced Control Research Laboratory in Urbana, Illinois led by mechanical…
-
Cloud Pharma, Univ of Florida Partner on Cancer Drug Design
17 March 2017. Cloud Pharmaceuticals, a company designing drug compounds with computer-based tools, and University of Florida’s medical school are collaborating on the design of new drugs limiting an enzyme implicated in the proliferation of cancer cells. Financial terms of the partnership were not disclosed. The agreement calls for the university’s Department of Medicine and…
-
U.K. Govt, Pharmas Form Dementia Research Fund
17 March 2015. A coalition of the United Kingdom government, five pharmaceutical companies, and the foundation Alzheimer’s Research UK are creating a $100 million fund to finance early research into treatments and cures for dementia. The U.K. health minister Jeremy Hunt is scheduled to unveil the Dementia Discovery Fund at a World Health Organization meeting…
-
Pittsburgh Alliance Applies Big Data to Health Innovations
16 March 2015. Three institutions in Pittsburgh, Pennsylvania — two universities and a medical center — are collaborating on innovations that make use of the rapidy growing pool of medical data, to develop new technologies that they say will change the way diseases are prevented, diagnosed, and treated. The alliance of Carnegie Mellon University, University…